The delivery of probiotics and prebiotics to infants

Current Pharmaceutical Design

Volumn 11, Issue 1, 2005, Pages 55-74

  Kullen, M J ^a   Bettler, J ^a  

^a PFIZER INC   (United States)

Author keywords

Bifidobacteria; Infant; Infant formula; Lactobacilli; Prebiotics; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CASEIN; INULIN; MALTODEXTRIN; MICROCRYSTALLINE CELLULOSE; OLIGOSACCHARIDE; ORAL REHYDRATION SOLUTION; PALMITIC ACID; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; YOGHURT;

ACUTE DIARRHEA; ACUTE GASTROENTERITIS; ARTIFICIAL MILK; ATOPY; BACTERIAL INFECTION; BIFIDOBACTERIUM; BODY WEIGHT DISORDER; BREAST FEEDING; CEREAL; CHILD GROWTH; CLINICAL TRIAL; DEHYDRATION; DISEASE EXACERBATION; DRUG CAPSULE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MARKETING; DRUG SAFETY; HUMAN; INFANT; INFANT FEEDING; INTESTINE FLORA; LACTIC ACID BACTERIUM; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS RHAMNOSUS; MYOCLONUS; NECROTIZING ENTEROCOLITIS; PREMATURITY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; STREPTOCOCCUS THERMOPHILUS; TREATMENT OUTCOME; VOMITING;

ACUTE DISEASE; ADMINISTRATION, ORAL; DIARRHEA, INFANTILE; HUMANS; INFANT; INFANT FORMULA; INFANT, NEWBORN; PROBIOTICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 12144261226     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612053382359     Document Type: Review

References (69)

1. Favier CF, Vaughan EE, De Vos WM, Akkermans AD. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002; 68(1): 219-26.
2. Rotimi VO, Duerden BI. The development of the bacterial flora in normal neonates. J Med Microbiol 1981; 14(1): 51-62.
3. Stark PL, Lee A. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J Med Microbiol 1982; 15(2): 189-203.
4. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 2000; 30(1): 61-7
5. Kleessen B, Bunke H, Tovar K, Noack J, Sawatzki G. Influence of two infant formulas and human milk on the development of the faecal flora in newborn infants. Acta Paediatr 1995; 84(12): 1347-56.
6. Mevissen-Verhage EA, Marcelis JH, de Vos MN, Harmsen-van Amerongen WC, Verhoef J. Bifidobacterium, Bacteroides, and Clostridium spp. in fecal samples from breast-fed and bottle-fed infants with and without iron supplement. J Clin Microbiol 1987; 25(2): 285-9.
7. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991; 88(1): 90-7.
8. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992; 32(2): 141-4.
9. Millar MR, Bacon C, Smith SL, Walker V, Hall MA. Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child 1993; 69: 483-7.
10. Stansbridge EM, Walker V, Hall MA, Smith SL, Millar MR, Bacon C, et al. Effects of feeding premature infants with Lactobacillus GG on gut fermentation. Arch Dis Child 1993; 69: 488-92.
11. Sepp E, Mikelsaar M, Salminen S. Effect of administration of Lactobacillus casei strain GG on the gastrointestinal microbiota of newborns. Microb Ecol Health D 1993; 6: 309.
12. Buts JP, Corthier G, Delmee M. Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants. J Pediatr Gastroenterol Nutr 1993; 16(4): 419-25.
13. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994; 344(8929): 1046-9.
14. Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995; 20(3): 333-8.
15. Langhendries JP, Detry J, Van Hees J, Lamboray JM, Darimont J, Mozin MJ, et al. Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J Pediatr Gastroenterol Nutr 1995; 21(2): 177-81.
16. Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T. Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child 1995; 72(1): 51-3.
17. Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T. Improved immunogenicity of oral D × RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995; 13(3): 310-2.
18. Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J 1995; 14(2): 107-11.
19. Siigur U, Tamm E, Torm S, Lutsar L, Salminen S, Midtvedt T. Microb Ecol Health D 1996; 9: 271.
20. Kok RG, de Waal A, Schut F, Welling GW, Weenk G, Hellingwerf KJ. Specific detection and analysis of a probiotic Bifidobacterium strain in infant Appl Environ Microbiol 1996; 62(10): 3668-72.
21. Shornikova AV, Casas IA, lsolauri E, Mykkanen H, Vesikari T. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr 1997; 24(4): 399-404.
22. Guerin-Danan C, Chabanet C, Pedone C, Popot F, Vaissade P, Bouley C, et al. Milk fermented with yogurt cultures and Lactobacillus casei compared with yogurt and gelled milk: influence on intestinal microflora in healthy infants. Am J Clin Nutr 1998; 67(1): 111-7.
23. Phuapradit P, Varavithya W, Vathanophas K, Sangchai R, Podhipak A, Suthutvoravut U, et al. Reduction of rotavirus infection in children receiving bifidobacteria-supplemented formula. J Med Assoc Thai 1999; 82 (Suppl 1): S43-8.
24. Urao M, Fujimoto T, Lane GJ, Seo G, Miyano T. Does probiotics administration decrease serum endotoxin levels in infants? J Pediatr Surg 1999; 34(2): 273-6.
25. Oberhelman RA, Gilman RH, Sheen P, Taylor DN, Black RE, Cabrera L, et al. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 1999; 134(1): 15-20.
26. Pedone CA, Bernabeu AO, Postaire ER, Bouley CF, Reinert P. The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. Int J Clin Pract 1999; 53(3): 179-84.
27. Arvola T, Laiho K, Torkkeli S, Mykkanen H, Salminen S, Maunula L, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999; 104(5): 64.
28. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999; 135(5): 564-8.
29. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30(11): 1604-10.
30. Simakachorn N, Pichaipat V, Rithipornpaisarn P, Kongkaew C, Tongpradit P, Varavithya W. Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children. J Pediatr Gastroenterol Nutr 2000; 30(1): 68-72.
31. Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 2000; 30(1): 54-60.
32. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357(9262): 1076-9.
33. Boudraa G, Benbouabdellah M, Hachelaf W, Boisset M, Desjeux JF, et al. Effect of feeding yogurt versus milk in children with acute diarrhea and carbohydrate malabsorption. J Pediatr Gastroenterol Nutr 2001; 33(3): 307-13.
34. Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002; 109(1): 119-21.
35. Mastretta E, Longo P, Laccisaglia A, Balbo L, Russo R, Mazzaccara A, et al. Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 2002; 35(4): 527-31.
36. Kankaanpaa PE, Yang B, Kallio HP, Isolauri E, Salminen SJ. Influence of probiotic supplemented infant formula on composition of plasma lipids in atopic infants. J Nutr Biochem 2002; 13(6): 364-369.
37. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002; 82(2): 103-8.
38. Chandra RK. Effect of Lactobacillus on the incidence and severity of acute rotavirus diarrhea in infants. A prospective placebo-controlled double-blind study. Nutr Res 2002; 22: 65-69.
39. Moro G, Minoli I, Mosca M, Fanaro S, Jelinek J, Stahl B, et al. Dosage-related bifidogenic effects of galacto- and fructooligo-saccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr 2002; 34(3): 291-5.
40. Boehm G, Lidestri M, Casetta P, Jelinek J, Negretti F, Stahl B, et al. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed 2002; 86(3): F178-81.
41. Agarwal R, Sharma N, Chaudhry R, Deorari A, Paul VK, Gewolb IH, et al. Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates. J Pediatr Gastroenterol Nutr 2003; 36(3): 397-402.
42. Costa-Ribeiro H, Ribeiro TC, Mattos AP, Valois SS, Neri DA, Almeida P, et al. Limitations of probiotic therapy in acute, severe dehydrating diarrhea. J Pediatr Gastroenterol Nutr 2003; 36(1): 112-5.
43. Schmelzle H, Wirth S, Skopnik H, Radke M, Knol J, Bockler HM, et al. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr 2003; 36(3): 343-51.
44. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361(9372): 1869-71.
45. Duggan C, Penny ME, Hibberd P, Gil A, Huapaya A, Cooper A, et al. Oligofructose-supplemented infant cereal: 2 randomized, blinded, community-based trials in Peruvian infants. Am J Clin Nutr 2003; 77(4): 937-42.
46. Bettler J, Mitchell DK, Kullen MJ. The safety and tolerance of toddler formulas containing Bifidobacterium lactis and fructo-oligosaccharide and their impact on the fecal microbiology of toddlers. 2004; In press.
47. Bettler J, Euler A. An evaluation of the growth of term infants fed forumula supplemented with fructo-oligosaccharide. 2004; In press.
48. Sanders ME. Probiotics: considerations for human health. Nutr Rev 2003; 61(3): 91-9.
49. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125(6): 1401-12.
50. Guandalini S. Acute Diarrhea. Pediatric Gastrointestinal Disease, 3rd Edition, Eds. Walker WA, Hamilton JR, Watkins JB, Durie PR, Walker-Smith JA 2000, BC Decker.
51. World Health Organization. 1995; Geneva: 1995.
52. Glass RI, Lew JF, Gangarosa RE, LeBaron CW, Ho MS. Estimates of morbidity and mortality rates for diarrheal diseases in American children. J Pediatr 1991; 118(4 (Pt 2): S27-33.
53. Shornikova AV, Isolauri E, Burkanova L, Lukovnikova S, Vesikari T. Atrial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta Paediatr 1997; 86(5): 460-5.
54. Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001; 138(3): 361-5.
55. Sanders ME, Morelli L, Bush S. "Lactobacillus sporogenes : is not a Lactobacillus probiotic. ASM News 2001; 67: 385.
56. Bartlett JG. Management of Clostridium difficile infection and other antibiotic-associated diarrhoeas. Eur J Gastroenterol Hepatol 1996; 8: 1054.
57. Lang DM, Polansky M. Patterns of asthma mortality in Philadelphia from 1969 to 1991. N Engl J Med 1994, 331(23): 1542-6.
58. Upton MN, McConnachie A, McSharry C, Hart CL, Smith GD, Gillis CR, et al. Intergenerational 20 year trends in the prevalence of asthma and hay fever in adults: the Midspan family study surveys of parents and offspring. BMJ 2000; 321(7253): 88-92.
59. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299(6710): 1259-60.
60. Bennet R, Eriksson M, Nord CE, Zetterstrom R. Fecal bacterial microflora of newborn infants during intensive care management and treatment with five antibiotic regimens. Pediatr Infect Dis 1986; 5(5): 533-9.
61. Sakata H, Yoshioka H, Fujita K. Development of the intestinal flora in very low birth weight infants compared to normal full-term newborns. Eur J Pediatr 1985; 144(2): 186-90.
62. Israel J, Morera C. Necrotizing Enterocolitis. Pediatric Gastrointestinal Disease, 3rd Edition, Eds. Walker WA, Hamilton JR, Watkins JB, Durie PR, Walker-Smith JA 2000, BC Decker.
63. Caplan MS, Jilling T. Neonatal necrotizing enterocolitis: possible role of probiotic supplementation. J Pediatr Gastroenterol Nutr 2000; 30 (Suppl 2): S18-22.
64. Caplan MS, MacKendrick W. Inflammatory mediators and intestinal injury. Clin Perinatol 1994; 21(2): 235-46.
65. Villari P, Sarnataro C, Iacuzio L. Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period. J Clin Microbiol 2000; 38(5): 1740-6.
66. Newburg DS. Oligosaccharides in human milk and bacterial colonization. J Pediatr Gastroenterol Nutr 2000; 30 (Suppl 2): S8-17.
67. Famularo G, Mosca L, Minisola G, Trinchieri V, De Simone C. Probiotic lactobacilli: a new perspective for the treatment of inflammatory bowel disease. Curr Pharm Design 2003; 9(24): 1973-80.
68. Kanauchi O, Mitsuyama K, Araki Y, Andoh A. Modification of intestinal flora in the treatment of inflammatory bowel disease. Curr Pharm Design 2003; 9(4): 333-46.
69. Mercenier A, Pavan S, Pot B. Probiotics as biotherapeatic agents: present knowledge and future prospects. Curr Pharm Design 2003; 9(2): 175-91.